• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 6-K filed by Lichen International Limited

    1/7/26 5:00:32 PM ET
    $LICN
    Professional Services
    Consumer Discretionary
    Get the next $LICN alert in real time by email
    6-K 1 licn6k010226.htm FORM 6-K

     

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

     

     

    FORM 6-K

     

     

     

    REPORT OF FOREIGN PRIVATE ISSUER
    PURSUANT TO RULE 13a-16 OR 15d-16
    UNDER THE SECURITIES EXCHANGE ACT OF 1934

     

    For the month ended January 2026

     

    Commission File No. 001-41493

     

    LICHEN INTERNATIONAL LIMITED
    (Translation of registrant’s name into English)

     

    15th Floor, Xingang Square, Hubin North Road,
    Siming District, Xiamen City,
    Fujian Province, China, 361013
    (Address of principal executive office)

     

    Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F

     

    Form 20-F ☒ Form 40-F ☐

     

     

     

     

     

     

    INFORMATION CONTAINED IN THIS FORM 6-K REPORT

     

    Results of Extraordinary General Meeting of Shareholders

     

    At the extraordinary general meeting of shareholders (the “Meeting”) of Lichen International Limited (the “Company”) convened on December 30, 2025, at 10:00 a.m., Beijing Time (December 29, 2025, at 9:00 p.m. Eastern Time), at 15th Floor, Xingang Square, Hubin North Road, Siming District, Xiamen City, Fujian Province, China, 361013, the shareholders of the Company adopted resolutions approving all of the six proposals considered at the Meeting. A total of 15,520,739 Class A Ordinary Shares, par value $0.008 per share of the Company, each of which is entitled to one vote per share, and 45,000 Class B Ordinary Shares, par value $0.008 per share of the Company, each of which is entitled to ten votes per share, collectively representing 15,970,739 voting power, accounting for 92.23% of the total voting power exercisable as of November 21, 2025, the record date, were present in person or by proxy at the Meeting. All matters voted on at the meeting were approved. The results of the votes, in voting power, were as follows:

     

    1.Proposal One – Share Capital Increase

     

    Resolution(s)  For   Against   Withheld/
    Abstain
     
    Proposal One: As an ordinary resolution, that (a) the increase of the authorized share capital of the Company from US$1,000,000.00 divided into (a) 100,000,000 series A ordinary shares of par value US$0.008 each and (b) 25,000,000 series B ordinary shares of par value US$0.008 each, to US$200,000,000.00 divided into (a) 20,000,000,000 series A ordinary shares of par value US$0.008 each and (b) 5,000,000,000 series B ordinary shares of par value US$0.008 each, by the creation of additional (a) 19,900,000,000 series A ordinary shares of par value US$0.008 each and (b) 4,975,000,000 series B ordinary shares of par value US$0.008 each to rank pari passu in all respects with the existing shares in the capital of the Company be and is hereby approved; and (b) any one director of the Company be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as he or she may consider necessary or desirable to give effect to the Share Capital Increase and the transactions contemplated thereunder and to attend to any necessary registration and/or filing in the Cayman Islands for and on behalf of the Company (the “Share Capital Increase”).   15,953,926    16,808       5 

     

    2.Proposal Two – Amendments of Articles

     

    Resolution(s)   For     Against     Withheld/
    Abstain
     

    Proposal Two: As a special resolution, that the Company’s existing amended and restated memorandum and articles of association be amended as follows:

     

    (1) by deleting article 39 of the Company’s existing amended and restated articles of association in its entirety and replacing it with the following:

    “39. The Company may, but shall not be obligated to, in each year hold a general meeting as an annual general meeting, which, if held, shall be convened by the Directors, in accordance with these Articles.”;

    (2) by deleting article 43 of the Company’s existing amended and restated articles of association in its entirety and replacing it with the following:

    “43. No business shall be transacted at any general meeting unless a quorum of Members is present at the time when the meeting proceeds to business; the quorum shall be:

    (a) if the Company has only one Member: that Member; or

    (b) if the Company has more than one Member

    (i) subject to Article 43(b)(ii), two or more Members; or

    (ii) subject to Article 45, for so long as any shares are listed on a Designated Stock Exchange, one or more Members holding shares that represent not less than one-third of the voting rights of the outstanding issued shares carrying the right to vote at such general meeting.”; and

    (3) by deleting article 45 of the Company’s existing amended and restated articles of association in its entirety and replacing it with the following:

    “45. If a quorum is not present within half an hour from the time appointed for the meeting to commence or if during such a meeting a quorum ceases to be present, the meeting, if convened upon a Members’ requisition, shall be dissolved, and in any other case it shall stand adjourned to the same day in the next week at the same time and/or place or to such other day, time and/or place as the Directors may determine, and if at the adjourned meeting a quorum is not present within half an hour from the time appointed for the meeting to commence, the Members present shall be a quorum.” (the “Amendments of Articles”).

        15,954,411       16,319    

     

    9

     

     

    1

     

     

    3. Proposal Three – the Share Consolidation

     

    Resolution(s)  For   Against   Withheld
    /Abstain
     
    Proposal Three: As an ordinary resolution, that (a) the consolidation of the Company’s issued and unissued series A and series B ordinary shares at a ratio of not less than one (1)-for-twenty (20) and not more than one (1)-for-two hundred (200) (the “Range”), with the exact ratio to be set at a whole number within the Range and the exact effective date to be determined by the board of directors of the Company (the “Board”) in its sole discretion within eighteen months after the date of passing of this resolution (the “Share Consolidation”), provided that no fractional share shall arise from the Share Consolidation, be and is hereby approved; (b) the rounding up of any fractional shares resulting from the Share Consolidation to the nearest whole ordinary share be and is hereby approved and (c) the Board be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as the Board considers necessary or desirable to give effect to the Share Consolidation and the transactions contemplated thereunder, including determining the exact ratio within the Range and the exact effective date of the Share Consolidation and instructing the registered office provider or transfer agent of the Company to complete the necessary corporate record(s) and filing(s) to reflect the Share Consolidation (the “Share Consolidation”).   15,954,471    16,261       7 

     

    4.Proposal Four – Adoption of the Amended and Restated Memorandum and Articles of Association

     

    Resolution(s)  For   Against   Withheld/
    Abstain
     
    Proposal four: As a special resolution, that subject to and conditional upon the passing of Resolutions One and Two above in respect of the Share Capital Increase and the Amendments of Articles, with immediate effect after the close of this meeting, (a) the amendment of the existing amended and restated memorandum and articles of association of the Company to reflect the Share Capital Increase and the Amendments of Articles be and hereby approved; (b) the amended and restated memorandum and articles of association of the Company (the “Amended and Restated Memorandum and Articles of Association”) be and are hereby approved and adopted as the new memorandum and articles of association of the Company in substitution for and to the exclusion of the existing amended and restated memorandum and articles of association of the Company and (c) any one director of the Company be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as he or she may consider necessary or desirable to give effect to the adoption of the Amended and Restated Memorandum and Articles of Association and the transactions contemplated thereunder and to attend to any necessary registration and/or filing in the Cayman Islands for and on behalf of the Company (the “Adoption of the Amended and Restated Memorandum and Articles of Association”).   15,953,905    16,823    11 

     

    2

     

     

    5.Proposal Five – the Amendment and Restatement of the Amended and Restated Memorandum and Articles of Association

     

    Resolution(s)  For   Against   Withheld/
    Abstain
     
    Proposal Five: As a special resolution, that subject to and conditional upon the passing of Resolutions One, Two and Three above in respect of the Share Capital Increase, the Amendments of Articles and the Share Consolidation, with effect from the effective date of the Share Consolidation, (a) the amendment of the amended and restated memorandum and articles of association of the Company as at the effective date of the Share Consolidation to reflect the Share Capital Increase, the Amendments of Articles and the Share Consolidation be and is hereby approved; (b) the amended and restated memorandum and articles of association of the Company be and are hereby approved and adopted as the new memorandum and articles of association of the Company in substitution for and to the exclusion of the amended and restated memorandum and articles of association of the Company as at the effective date of the Share Consolidation and (c) any one director of the Company be and is hereby authorised to do all such acts and things and execute all such documents, including under seal where applicable, as he or she may consider necessary or desirable to give effect to the amendment of the amended and restated memorandum and articles of association of the Company and the transactions contemplated thereunder and to attend to any necessary registration and/or filing in the Cayman Islands for and on behalf of the Company (the “Amendment and Restatement of the Amended and Restated Memorandum and Articles of Association”).   15,954,470    16,208    61 

     

    6.Proposal Six – Adjourn of the Meeting

     

    Resolution(s)  For   Against   Withheld/
    Abstain
     
    Proposal Six: As an ordinary resolution, that the Meeting be and is adjourned to a later date or dates, if necessary, to permit further solicitation and vote of proxies in the event that there are insufficient votes for, or otherwise in connection with, the approval of Resolution One above, Resolution Two above, Resolution Three above, Resolution Four and/or Resolution Five above (the “Adjournment of the Meeting”).   15,956,197    14,481    61 

     

    3

     

     

    The Company’s Amended and Restated Memorandum and Articles of Association is filed as Exhibit 3.1 to this Current Report on Form 6-K.

     

    EXHIBIT INDEX

     

    Exhibit No.   Description
    3.1   Amended and Restated Memorandum and Articles of Association

     

    4

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

     

    Date: January 7, 2026 Lichen International Limited
       
      By: /s/ Ya Li
      Name:  Ya Li
      Title: Chief Executive Officer, Chairman of the Board, and Director

     

    5

     

    Get the next $LICN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $LICN

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $LICN
    SEC Filings

    View All

    SEC Form 6-K filed by Lichen International Limited

    6-K - Lichen International Ltd (0001876766) (Filer)

    1/7/26 5:00:32 PM ET
    $LICN
    Professional Services
    Consumer Discretionary

    SEC Form 6-K filed by Lichen International Limited

    6-K - Lichen International Ltd (0001876766) (Filer)

    12/11/25 4:30:15 PM ET
    $LICN
    Professional Services
    Consumer Discretionary

    SEC Form EFFECT filed by Lichen International Limited

    EFFECT - Lichen International Ltd (0001876766) (Filer)

    12/11/25 12:15:18 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    $LICN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Lichen China Limited Announces Effective Date of Reverse Stock Split and Name Change

    XIAMEN, China, Feb. 27, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced the date of effectiveness and the ratio of a forthcoming reverse stock split (the "Reverse Split") of the Company's ordinary shares (the "Ordinary Shares"). On February 12, 2025, the Company announced, on a Current Report on Form 6-K, the voting results from the annual meeting of shareholders (the "Meeting") held on February 10, 2025. At the Meeting, shareholders voted upon and approved Proposal 2 to effect a Reverse Split with a ratio of not less than one-for-twenty and not more than one-for-two-hundr

    2/27/25 8:30:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    Lichen China Limited Announces Receipt of Nasdaq Delisting Notice Subject to Hearing Request

    XIAMEN, China, Feb. 18, 2025 /PRNewswire/ -- Lichen China Limited (Nasdaq: LICN) ("Lichen China" or the "Company"), a dedicated financial and taxation service provider in China today announced that it has received a letter from The Nasdaq Stock Market LLC ("Nasdaq"), notifying that the Company is not in compliance with Nasdaq Listing Rule 5810(c)(3)(A)(iii) (the "Low Priced Stocks Rule"), as the Company's securities had a closing bid price of $0.10 or less for eleven consecutive trading days from January 28, 2025 through February 11, 2025. The letter indicated that, as a result, the Nasdaq staff has determined to delist the Company's ordinary shares from The Nasdaq Capital Market (the "Delis

    2/18/25 8:00:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration

    XIAMEN, China, Feb. 10, 2025 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China") (NASDAQ:LICN), a leading financial and taxation service provider in China, today announced the completion of its acquisition of the remaining 40% equity interest in Bondly Enterprises Limited ("Bondly"), a prominent domestic consulting firm specializing in business process management and informationization. This acquisition follows Lichen China's initial purchase of 60% equity in Bondly in 2024, and marks a significant step in Lichen China's strategy to fully integrate Bondly's advanced technologies and AI capabilities into its operations. The acquisition, valued at US$5,330,000, underscores

    2/10/25 8:00:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    $LICN
    Leadership Updates

    Live Leadership Updates

    View All

    Lichen China Limited Announces Appointment of Robert Bodenstein to Board of Directors

    XIAMEN, China, Feb. 27, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, announced the appointment of Mr. Robert Bodenstein to its board of directors, effective February 26, 2024. Mr. Bodenstein will serve as an independent director as well as a member of the Nominating, Compensation and Audit Committees. Mr. Bodenstein, with over 40 years of experience in the management consulting industry, serves as the Chair of the International Council of Management Consulting Institutes (ICMCI), a global alliance of management consulting institutes, recognized by the United Nations Economic and Social

    2/27/24 8:00:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    $LICN
    Financials

    Live finance-specific insights

    View All

    Lichen China Limited Acquires Remaining Equity in Bondly Enterprises to Strengthen AI Development and Business Integration

    XIAMEN, China, Feb. 10, 2025 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China") (NASDAQ:LICN), a leading financial and taxation service provider in China, today announced the completion of its acquisition of the remaining 40% equity interest in Bondly Enterprises Limited ("Bondly"), a prominent domestic consulting firm specializing in business process management and informationization. This acquisition follows Lichen China's initial purchase of 60% equity in Bondly in 2024, and marks a significant step in Lichen China's strategy to fully integrate Bondly's advanced technologies and AI capabilities into its operations. The acquisition, valued at US$5,330,000, underscores

    2/10/25 8:00:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary

    Lichen China Limited Announced Financial Results for Fiscal Year 2023

    XIAMEN, China, April 5, 2024 /PRNewswire/ -- Lichen China Limited (the "Company" or "Lichen China")(NASDAQ:LICN), a dedicated financial and taxation service provider in China, today announced its financial results for the fiscal year ended December 31, 2023. FY 2023 Financial Highlights: Revenue increased approximately $5.95 million or 17.61% to approximately $39.76 million for the year ended December 31, 2023, as compared with approximately $33.81 million for the fiscal year ended December 31, 2022. The increase was primarily due to continuous expansion of the branding and business that brought new clients and orders.Gross profit was approximately $24.32 million for the fiscal year ended D

    4/5/24 8:00:00 AM ET
    $LICN
    Professional Services
    Consumer Discretionary